Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Breast

Explore clinical trials studying Neoplasms, Breast. Study availability and eligibility vary by location and protocol.

51 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Neoplasms, Breast trial results

Completed

Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer

NCT00263588

Conditions
Brain Diseases, Brain Neoplasms, Breast Diseases, +10 more
Locations
  • Novartis Investigative Site San Francisco, California, United States
  • Novartis Investigative Site Vallejo, California, United States
  • Novartis Investigative Site Denver, Colorado, United States
  • Novartis Investigative Site Washington D.C., District of Columbia, United States
View all 74 locations
View Trial Details
Completed

Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBC

NCT00709761

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • Novartis Investigative Site La Verne, California, United States
  • Novartis Investigative Site Long Beach, California, United States
  • Novartis Investigative Site Fort Myers, Florida, United States
  • Novartis Investigative Site Atlanta, Georgia, United States
View all 13 locations
View Trial Details
Completed

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

NCT00790816

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • Novartis Investigative Site Scottsdale, Arizona, United States
  • Novartis Investigative Site Tucson, Arizona, United States
  • Novartis Investigative Site Santa Monica, California, United States
  • Novartis Investigative Site Washington D.C., District of Columbia, United States
View all 23 locations
View Trial Details
Completed

Study Of Ispinesib In Subjects With Breast Cancer

NCT00089973

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • GSK Investigational Site Jacksonville, Florida, United States
  • GSK Investigational Site Indianapolis, Indiana, United States
  • GSK Investigational Site Chapel Hill, North Carolina, United States
  • GSK Investigational Site Pittsburgh, Pennsylvania, United States
View all 13 locations
View Trial Details

Related conditions